TD HEALTH SCIENCES FUND $17.15

Article Excerpt

TD HEALTH SCIENCES FUND $17.15 (CWA Rating: Speculative) (TD Asset Management, P.O. Box 7500, Station A, Toronto, Ontario. M5W 1P9. 1-800-463-3863; Web site: www.tdcanadatrust.ca. No load — deal directly with the bank) invests mostly in U.S. companies with a mixture of large-capitalization stocks and earlier-stage biotechnology shares. The managers believe all these firms will profit from an aging population stimulating higher spending on health care, drugs and research. The fund’s top holdings include WellPoint, Amgen, Sepracor, CVS/Caremark, Genentech, Gilead Sciences, UnitedHealth Group, Wyeth, Roche Holdings and Cephalon. Its MER is 2.78%. The $238.3 million fund’s manager is well-known U.S. fund manager T. Rowe Price Associates. TD Health Sciences gained 3.0% over the last year. It’s up 11.2% in the last six months. TD Health Sciences Fund is still a buy. buy…